KLOW
KLOW
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
KLOW Blend Overview
The KLOW Blend combines GHK-Cu, BPC-157, TB-500, and KPV into a single formulation studied for its potential influence on molecular signaling and systemic regulation. In laboratory and preclinical models, these peptides have been investigated for their effects on matrix remodeling, angiogenesis, cytokine modulation, and extracellular matrix activity. Together, they provide a platform for exploring synergistic pathways in molecular dynamics, immune signaling, and vascular biology.
History
The KLOW Blend draws on several decades of peptide research. GHK-Cu, first identified in biological plasma samples in the 1970s, has been studied for gene expression and matrix signaling. BPC-157, synthesized in the 1990s as a gastric protein fragment analog, has been explored for angiogenic and structural processes. TB-500, derived from thymosin beta-4 research in the 1960s, has been examined for angiogenesis and molecular migration. KPV, a C-terminal fragment of α-MSH, has been evaluated for cytokine-modulating and immunomodulatory activity. Collectively, these peptides represent areas of ongoing investigation into experimental biology, vascular pathways, and immune signaling. The KLOW Blend is intended for research use only.
GHK-Cu Structure
Molecular Formula: C₁₄H₂₄CuN₆O₄
Molecular Weight: 340.9 g/mol
PubChem ID: 5311476
BPC-157 Structure
Molecular Formula: C₁₄H₂₄CuN₆O₄
Molecular Weight: 340.9 g/mol
PubChem ID: 5311476
TB-500 Structure
Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: 4963.5 g/mol
PubChem ID: 16132321
KPV Structure
Formula: C₁₆H₂₈N₆O₅
Molecular Weight: 388.4 g/mol
PubChem ID: 16129619
Research Findings
The KLOW Blend, which combines GHK-Cu, BPC-157, TB-500, and KPV, has been studied in structural, vascular, epithelial, and systemic models. Research highlights activity in collagen formation, extracellular matrix remodeling, angiogenesis, molecular migration, and cytokine modulation. The inclusion of KPV further supports immune signaling and cytokine-modulating pathways, expanding the experimental scope of this blend in preclinical settings.
Key Areas of Research:
-
Structural: Collagen, matrix, connective signaling
-
Vascular: Angiogenesis, nitric oxide, remodeling
-
Epithelial: Migration, matrix signaling, follicle dynamics
-
Systemic: Cytokine modulation, immune signaling, pathway dynamics
Together, these findings suggest broad experimental potential for the KLOW Blend across multiple biological pathways. By combining structural support, vascular and epithelial activity, and immune signaling, the KLOW Blend provides a versatile platform for research into molecular dynamics, matrix characterization, and systemic resilience in laboratory settings.